Gastrointestinal Infection Before Immune Checkpoint Inhibition Hinders Treatment Efficacy and Increases the Risk of Colitis

Malek Shatila, Kian Abdul-Baki, Andres Urias Rivera, Kei Takigawa, Irene Jeong Ah Lee, Andrew Sullivan, Tanvi Gupta, Linfeng Lu, Raakhi Menon, Ayesha Khan, Hamza Salim, Elliot Baerman, Carolina Colli Cruz, Cristina Natha, Varun Vemulapalli, Garrett Coleman, Krishnavathana Varatharajalu, Christopher Fan, Pablo Okhuysen, Anthony J. OlszanskiYan Zhou, Hao Chi Zhang, Mehnaz Shafi, Yinghong Wang

Cancer Signaling and Microenvironment (CSM)
Center for Immunology
Hematology Oncology

University of Texas MD Anderson Cancer Center
University of Texas Medical Branch at Galveston
Baylor College of Medicine
University of Texas Health Science Center at Houston
Memorial Hermann Healthcare System
Houston Methodist

Research output: Contribution to journal › Article › peer-review

Sort by
Weight
Alphabetically

Gastrointestinal Infection Before Immune Checkpoint Inhibition Hinders Treatment Efficacy and Increases the Risk of Colitis

Fingerprint

Pharmacology, Toxicology and Pharmaceutical Science